Key Record Dates
ClinicalTrials.gov Identifier: | NCT04222972 |
---|---|
Brief Title: | AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive, Metastatic NSCLC |
First Submitted : | January 3, 2020 |
First Submitted that Met QC Criteria : | January 7, 2020 |
First Posted : | January 10, 2020 |
Last Update Submitted that Met QC Criteria : | October 28, 2020 |
Last Update Posted : | October 30, 2020 |